MOLECULAR MIMICRY AND POST-INFECTIOUS AUTOIMMUNITY: PATHOPHYSIOLOGICAL MECHANISMS OF AUTOIMMUNE ENCEPHALITIS MANIFESTATION FOLLOWING VIRAL INFECTIONS
DOI:
https://doi.org/10.37547/Keywords:
Molecular mimicry; autoimmune encephalitis; anti-NMDA receptor encephalitis; post-infectious autoimmunity; herpes simplex virus encephalitis; bystander activation; epitope spreading; neuroimmunology.Abstract
Autoimmune encephalitis (AIE) has emerged as one of the most clinically significant discoveries in contemporary neuroimmunology, reshaping the differential diagnosis of patients presenting with subacute psychiatric symptoms, seizures, and cognitive decline. A growing body of evidence links the onset of several forms of AIE, most notably anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, to a preceding viral infection of the central nervous system, particularly herpes simplex virus type 1 (HSV-1) encephalitis. This article reviews the pathophysiological mechanisms by which viral infections can precipitate autoimmune neurological disease, with particular emphasis on molecular mimicry as a mechanistic framework, alongside complementary processes such as bystander activation, epitope spreading, and virus-induced blood-brain barrier disruption. The post-herpetic anti-NMDAR encephalitis model is examined as the paradigmatic example of post-infectious autoimmune encephalitis, illustrating how neuronal antigens released during viral cytolysis can become targets of a maladaptive humoral immune response. Understanding these mechanisms carries direct clinical relevance, as recognizing the temporal relationship between viral encephalitis and subsequent neurological relapse can guide earlier immunotherapy and improve patient outcomes.
Downloads
References
1. Suyunov N.D., Masharipova R.R., Khasanov F.O. Theoretical analysis of rheumatic diseases and the medicines used in them [Ревматизм касалликлари ва унда қўлланиладиган дори воситаларининг назарий таҳлили]. Tashkent Pharmaceutical Institute, Department of Pharmaceutical Organization, 2023.
2. Alimov A.V., Sadikova A.S., Matchanov S.Kh., Muminova S.A. Association of autoimmune thyroiditis and rheumatoid arthritis: analysis of clinical and laboratory data. Problems of Biology and Medicine. 2025;№2.1(160):34.
3. Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42(1):102-111.
4. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80-94.
5. Rojas M, Restrepo-Jiménez P, Monsalve DM, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100-123.
6. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25-36.
7. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091-1098.
8. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30(17):5866-5875.
9. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157-165.
10. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol. 2012;72(6):902-911.
11. Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760-772.
12. Höftberger R, Armangue T, Leypoldt F, Graus F, Dalmau J. Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-D-aspartate receptor antibodies are part of the problem. Clin Neuropathol. 2013;32(4):251-254.
13. Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97(2):839-887.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.